A Pilot Study of BMS-936558 With Stereotactic Ablative Radiation Therapy After Induction Chemotherapy in Cholangiocarcinoma
Latest Information Update: 26 Dec 2022
At a glance
- Drugs Nivolumab (Primary)
- Indications Cholangiocarcinoma
- Focus Therapeutic Use
- Acronyms NATCHO
- 12 Dec 2022 Trial design published in the BMC Cancer
- 07 Feb 2022 Status changed from recruiting to discontinued.
- 22 Jul 2021 Planned End Date changed from 15 May 2024 to 15 Nov 2024.